(function(){
			var content_array=["<p><strong><em>About NanoMaterials Technology Private Limited (<\/em><\/strong><a href=\"http:\/\/www.nanomt.com\/\" rel=\"nofollow\" target=\"_blank\"><strong><em>http:\/\/www.nanomt.com<\/em><\/strong><\/a><strong><em>)<\/em><\/strong><\/p>\r\n<p><em>Founded in April 2000, NanoMaterials Technology (NMT) is a Singapore company that specializes in the development and commercialization of nano-materials. NMT has a proprietary technology called High Gravity Controlled Precipitation (HGCP), which is originally invented and developed by Prof. Jianfeng Chen, one of NMT's founders, and Beijing University of Chemical Technology, one of its shareholders. The technology was internationalized and further improved by NMT, which results in a mass production technology that is simple and extremely cost effective. The HGCP technology is versatile to be coupled with NMT's patented dispersion technology and know how to improve the dispersibility of the nano-particles in pharmaceutical and specialty products.<\/em><\/p>\r\n<p><strong><em>About CHRISTUS Stehlin Foundation for Cancer Research (<\/em><\/strong><a href=\"http:\/\/stehlin.org\/\" rel=\"nofollow\" target=\"_blank\"><strong><em>http:\/\/stehlin.org<\/em><\/strong><\/a><strong><em>)<\/em><\/strong><\/p>\r\n<p><em>Founded in 1969 by surgical oncologist, Dr. John S. Stehlin, Jr., CHRISTUS Stehlin Foundation for Cancer Research (Stehlin Foundation) has been widely recognized in the scientific world as a pioneer in cancer research and treatment with more than 500 scientific publications. The purpose of the Foundation is to conduct cancer research that can be applied directly to improving the treatment of the patient. All research is clinically oriented. This has shortened the time from the test tube to treatment, resulting in thousands of cancer patients who are alive today. The Stehlin Foundation has a state-of-the-art 27,000 square foot research facility in Houston. Besides drug development, the Foundation also works on various research projects including prostate cancer, hyperthermia, Desmoplastic small-round-cell tumor (DSRCT) and the development of the humanized mouse.<\/em><\/p>\r\n<p>Media Contact Details:<\/p>\r\n<p>NanoMaterials Technology Private Limited <br \/> Tel: +65-9384-1818 <br \/> Ms Grace Yeo, <a href=\"mailto:grace.yeo@nanomt.com\" rel=\"nofollow\" target=\"_blank\">grace.yeo@nanomt.com<\/a><\/p>"];
			$("#dvExtra").html(content_array[0]);})();